High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with (99m)Tc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin.
Cancer Chemother Pharmacol
; 74(1): 211-5, 2014 Jul.
Article
em En
| MEDLINE
| ID: mdl-24817602
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Pleurais
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Tecnécio
/
Cisplatino
/
Compostos Radiofarmacêuticos
/
Mesotelioma
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cancer Chemother Pharmacol
Ano de publicação:
2014
Tipo de documento:
Article